Amy Lynch
Associate Director, Operations and Project Management at TCR2 Therapeutics - Cambridge, MA, US
Amy Lynch's Colleagues at TCR2 Therapeutics
Tony Barnitz
Associate Director - Manufacturing Sciences and Technologies (MSAT)
Amy Lynch's Contact Details
617-949-5200
Greater Boston Area
TCR2 Therapeutics
Amy Lynch's Company Details
TCR² Therapeutics Inc. is a clinical-stage cell therapy company developing a pipeline of novel T cell therapies for patients suffering from solid tumors. The company is focused on the discovery and development of product candidates against novel and complex targets utilizing its proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC®-T cells). The TRuC platform is designed to specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). For more information about TCR², please visit www.tcr2.com.